Correlation Between Nu Med and Accuray Incorporated

Can any of the company-specific risk be diversified away by investing in both Nu Med and Accuray Incorporated at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nu Med and Accuray Incorporated into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nu Med Plus and Accuray Incorporated, you can compare the effects of market volatilities on Nu Med and Accuray Incorporated and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nu Med with a short position of Accuray Incorporated. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nu Med and Accuray Incorporated.

Diversification Opportunities for Nu Med and Accuray Incorporated

-0.46

Correlation Coefficient

Nu Med  Accuray Incorporated

Very good diversification

The 3 months correlation between NUMD and Accuray is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Nu Med Plus and Accuray Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accuray Incorporated and Nu Med is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nu Med Plus are associated (or correlated) with Accuray Incorporated. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accuray Incorporated has no effect on the direction of Nu Med i.e., Nu Med and Accuray Incorporated go up and down completely randomly.

Pair Corralation between Nu Med and Accuray Incorporated

Given the investment horizon of 90 days Nu Med Plus is expected to under-perform the Accuray Incorporated. In addition to that, Nu Med is 1.89 times more volatile than Accuray Incorporated. It trades about -0.07 of its total potential returns per unit of risk. Accuray Incorporated is currently generating about 0.04 per unit of volatility. If you would invest  195.00  in Accuray Incorporated on October 20, 2024 and sell it today you would earn a total of  29.00  from holding Accuray Incorporated or generate 14.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Nu Med Plus  vs.  Accuray Incorporated

Nu Med Plus

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nu Med Plus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Accuray Incorporated

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Accuray Incorporated are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Accuray Incorporated showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nu Med and Accuray Incorporated

The main advantage of trading using opposite Nu Med and Accuray Incorporated positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nu Med position performs unexpectedly, Accuray Incorporated can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accuray Incorporated will offset losses from the drop in Accuray Incorporated's long position.

The idea behind Nu Med Plus and Accuray Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.